Leukemia evolving from paroxysmal nocturnal hemoglobinuria

Leukemia. 2020 Jan;34(1):327-330. doi: 10.1038/s41375-019-0555-0. Epub 2019 Aug 20.

Authors

Hassan Awada¹, Shafia Rahman¹, Jibran Durrani¹, Mohammad F Asad¹, Cassandra M Kerr¹, Vera Adema¹, Ashwin Kishtagari¹, Amy Graham¹, Christina A Snider¹, Sunisa Kongkiatkamon¹, Yasunobu Nagata¹, Bhumika J Patel², Hetty E Carraway², Mikkael A Sekeres^{1

2}, Jaroslaw P Maciejewski^{1

2}, Valeria Visconte³

Affiliations

¹ Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
² Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
³ Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. [email protected].

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Cell Transformation, Neoplastic / genetics
Cell Transformation, Neoplastic / pathology
Female
Hemoglobinuria, Paroxysmal / genetics*
Hemoglobinuria, Paroxysmal / pathology*
Humans
Leukemia / genetics*
Leukemia / pathology*
Male
Middle Aged
Young Adult

Grants and funding